Sale!

FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test is a specialized diagnostic tool used to identify mutations in the FLNA gene, which are linked to the development of intestinal pseudo-obstruction. This condition is a severe disorder characterized by the symptoms of bowel obstruction without any physical blockage, affecting the patient’s ability to digest food and absorb nutrients properly. It is a rare, often debilitating condition that can present from infancy, affecting both males and females, but with a noted severity in males due to the gene’s location on the X chromosome.

DNA Labs UAE offers this cutting-edge genetic test, priced at 4400 AED, to patients who exhibit symptoms of intestinal pseudo-obstruction, or have a family history of the disorder, providing a critical tool for accurate diagnosis. By analyzing the patient’s DNA, the test can detect mutations in the FLNA gene, enabling healthcare providers to make informed decisions about treatment strategies, manage symptoms more effectively, and offer genetic counseling to affected families. The availability of such a test represents a significant step forward in the personalized treatment of rare genetic disorders, offering hope and improved quality of life to those affected.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test

At DNA Labs UAE, we offer the FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test to help diagnose genetic disorders related to the FLNA gene. This test can provide valuable insights into the structure and function of cells, specifically in relation to intestinal pseudoobstruction and neuronal abnormalities.

Test Details

The FLNA gene is responsible for producing the protein filamin A, which is essential for cell structure and function. Mutations in this gene can lead to various genetic disorders, including intestinal pseudoobstruction and neuronal abnormalities.

Intestinal pseudoobstruction is a condition characterized by impaired movement of the intestines, resulting in symptoms similar to a mechanical obstruction, such as severe abdominal pain, bloating, and constipation. However, unlike a physical blockage, this condition is caused by mutations in the FLNA gene, affecting the normal functioning of smooth muscle cells in the intestines.

Neuronal abnormalities can also be associated with FLNA gene mutations. These abnormalities can affect the development and function of neurons in the brain and spinal cord, leading to a range of neurological symptoms. These may include intellectual disability, developmental delays, seizures, and abnormal muscle tone.

To diagnose FLNA gene-related disorders, we utilize Next-Generation Sequencing (NGS) technology. NGS is a high-throughput sequencing method that allows for the analysis of multiple genes simultaneously. This enables the detection of mutations in the FLNA gene and other genes associated with similar conditions.

The FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test involves sequencing the individual’s DNA and comparing it to a reference genome to identify any genetic variations or mutations. This test can confirm a diagnosis, guide treatment decisions, and provide information about the risk of passing on the condition to future generations.

Test Information

  • Test Name: FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient, Genetic Counselling session to draw a pedigree chart of affected family members

Conclusion

The FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test offered by DNA Labs UAE is a valuable tool for diagnosing FLNA gene-related disorders. By utilizing NGS technology, we can provide accurate and comprehensive results to guide treatment decisions and provide support to individuals and families. If you or a loved one are experiencing symptoms suggestive of an FLNA gene-related disorder or have a family history of the condition, we recommend considering this genetic test.

Test Name FLNA Gene Intestinal pseudoobstraction neuronal Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FLNA Gene Intestinal pseudoobstraction, neuronal NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with FLNA Gene Intestinal pseudoobstraction, neuronal
Test Details

The FLNA gene is responsible for producing the protein filamin A, which plays a critical role in the structure and function of cells. Mutations in the FLNA gene can lead to various genetic disorders, including intestinal pseudoobstruction and neuronal abnormalities.

Intestinal pseudoobstruction is a condition characterized by impaired movement of the intestines, leading to symptoms similar to a mechanical obstruction, such as severe abdominal pain, bloating, and constipation. However, in intestinal pseudoobstruction, there is no physical blockage present. This condition can be caused by mutations in the FLNA gene, which affect the normal functioning of the smooth muscle cells in the intestines.

Neuronal abnormalities can also be associated with FLNA gene mutations. These abnormalities can affect the development and function of neurons in the brain and spinal cord, leading to a range of neurological symptoms. These may include intellectual disability, developmental delays, seizures, and abnormal muscle tone.

To diagnose FLNA gene-related disorders, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing technology that can analyze multiple genes simultaneously, allowing for the detection of mutations in the FLNA gene and other genes associated with similar conditions. This test involves sequencing the individual’s DNA and comparing it to a reference genome to identify any genetic variations or mutations.

The NGS genetic test for FLNA gene-related disorders can help confirm a diagnosis, guide treatment decisions, and provide information about the risk of passing on the condition to future generations. It is typically performed on individuals who have symptoms suggestive of an FLNA gene-related disorder or those with a family history of the condition. Genetic counseling is often recommended before and after the test to discuss the implications of the results and provide support to individuals and families.